Joseph R Geraghty1, Fernando D Testai2. 1. Department of Neurology & Rehabilitation, University of Illinois at Chicago College of Medicine, 912 S. Wood St. Suite 174N, Chicago, IL, 60612, USA. Jgerag2@uic.edu. 2. Department of Neurology & Rehabilitation, University of Illinois at Chicago College of Medicine, 912 S. Wood St. Suite 174N, Chicago, IL, 60612, USA.
Abstract
PURPOSE OF REVIEW: Delayed cerebral ischemia (DCI) is common after subarachnoid hemorrhage (SAH) and represents a significant cause of poor functional outcome. DCI was mainly thought to be caused by cerebral vasospasm; however, recent clinical trials have been unable to confirm this hypothesis. Studies in humans and animal models have since supported the notion of a multifactorial pathophysiology of DCI. This review summarizes some of the main mechanisms under investigation including cerebral vascular dysregulation, microthrombosis, cortical spreading depolarizations, and neuroinflammation. RECENT FINDINGS: Recent guidelines have differentiated between DCI and angiographic vasospasm and have highlighted roles of the microvasculature, coagulation and fibrinolytic systems, cortical spreading depressions, and the contribution of the immune system to DCI. Many therapeutic interventions are underway in both preclinical and clinical studies to target these novel mechanisms as well as studies connecting these mechanisms to one another. Clinical trials to date have been largely unsuccessful at preventing or treating DCI after SAH. The only successful pharmacologic intervention is the calcium channel antagonist, nimodipine. Recent studies have provided evidence that cerebral vasospasm is not the sole contributor to DCI and that additional mechanisms may play equal if not more important roles.
PURPOSE OF REVIEW: Delayed cerebral ischemia (DCI) is common after subarachnoid hemorrhage (SAH) and represents a significant cause of poor functional outcome. DCI was mainly thought to be caused by cerebral vasospasm; however, recent clinical trials have been unable to confirm this hypothesis. Studies in humans and animal models have since supported the notion of a multifactorial pathophysiology of DCI. This review summarizes some of the main mechanisms under investigation including cerebral vascular dysregulation, microthrombosis, cortical spreading depolarizations, and neuroinflammation. RECENT FINDINGS: Recent guidelines have differentiated between DCI and angiographic vasospasm and have highlighted roles of the microvasculature, coagulation and fibrinolytic systems, cortical spreading depressions, and the contribution of the immune system to DCI. Many therapeutic interventions are underway in both preclinical and clinical studies to target these novel mechanisms as well as studies connecting these mechanisms to one another. Clinical trials to date have been largely unsuccessful at preventing or treating DCI after SAH. The only successful pharmacologic intervention is the calcium channel antagonist, nimodipine. Recent studies have provided evidence that cerebral vasospasm is not the sole contributor to DCI and that additional mechanisms may play equal if not more important roles.
Authors: Jared M Pisapia; Xiangsheng Xu; Jane Kelly; Jamie Yeung; Geneive Carrion; Huaiyu Tong; Sudha Meghan; Omar M El-Falaky; M Sean Grady; Douglas H Smith; Sergei Zaitsev; Vladimir R Muzykantov; Michael F Stiefel; Sherman C Stein Journal: Exp Neurol Date: 2011-11-04 Impact factor: 5.330
Authors: Jose Javier Provencio; Valerie Swank; Haiyan Lu; Sylvain Brunet; Selva Baltan; Rohini V Khapre; Himabindu Seerapu; Olga N Kokiko-Cochran; Bruce T Lamb; Richard M Ransohoff Journal: Brain Behav Immun Date: 2016-02-09 Impact factor: 7.217
Authors: Daniel Hänggi; Nima Etminan; Francois Aldrich; Hans Jakob Steiger; Stephan A Mayer; Michael N Diringer; Brian L Hoh; J Mocco; Herbert J Faleck; R Loch Macdonald Journal: Stroke Date: 2016-12-08 Impact factor: 7.914
Authors: Yonatan Hirsch; Joseph R Geraghty; Cory R Reiter; Eitan A Katz; Conner F Little; Matthew K Tobin; Fernando D Testai Journal: Transl Stroke Res Date: 2022-05-06 Impact factor: 6.829
Authors: Andrew Silverman; Sreeja Kodali; Sumita Strander; Emily J Gilmore; Alexandra Kimmel; Anson Wang; Branden Cord; Guido Falcone; Ryan Hebert; Charles Matouk; Kevin N Sheth; Nils H Petersen Journal: Stroke Date: 2019-09-09 Impact factor: 7.914
Authors: Joseph R Geraghty; Melissa N Lara-Angulo; Milen Spegar; Jenna Reeh; Fernando D Testai Journal: J Stroke Cerebrovasc Dis Date: 2020-06-20 Impact factor: 2.136
Authors: Julian V Clarke; Julia M Suggs; Deepti Diwan; Jin V Lee; Kim Lipsey; Ananth K Vellimana; Gregory J Zipfel Journal: J Cereb Blood Flow Metab Date: 2020-04-28 Impact factor: 6.200